Customer care

Terms of Service

Last updated: 13 July 2026

This online store is operated by Biora Lab Pte. Ltd. By using the site or placing an order, you agree to these terms together with the Privacy, Shipping and Refund Policies.

Products and information

BioraLab products are wellness supplements. Product information is provided for general information and is not medical advice. Products are not intended to diagnose, prevent, treat or cure disease. Follow the label, serving directions, storage instructions and warnings. Speak with a healthcare professional if you are pregnant, breastfeeding, taking medication or under medical supervision.

Orders and pricing

Prices are displayed in the selected currency. Applicable taxes, shipping charges and available delivery options are shown at checkout. An order is subject to payment authorisation and product availability. BioraLab may cancel or decline an order affected by an obvious pricing error, unavailable stock, suspected fraud or incomplete delivery information; any captured payment for a cancelled order will be returned through the original payment method.

Website use

You may not misuse the site, interfere with its operation, submit unlawful content or use BioraLab branding and content without permission. Product photography and colours may vary slightly by screen and production batch.

Customer content

Reviews are considered for publication only after order matching and customer permission. BioraLab may edit approved customer content for length or clarity without changing its meaning and will not publish medical treatment claims.

Contact

Questions about these terms can be sent to hello@biora-lab.com.

1. G4 patent application pending in China.
2&3. Based on self-reported participant feedback from a 28-day product trial (n=33). Individual results may vary.
4. G4 Patent application pending in China.
5. Based on in-vitro laboratory testing of G4. Ingredient information is based on；ingredient-level research and specifications and does not represent clinical outcomes of the finished product. Based on self-reported participant feedback from a 28-day product trial (n=33). Individual results may vary.
6. based on in-vitro strain testing; 73% refers to α-glucosidase activity under laboratory conditions. Not a human clinical outcome; no effect on carbohydrate absorption or blood glucose is implied.
7. published in-vitro study; 57.9% refers to AGE formation inhibition in a BSA–fructose model.
8. published in-vitro study; 75.2% refers to CML formation inhibition in a BSA–glucose model. CML is an advanced glycation end-product.
9. Enzogenol® + vitamin C: published human study, n=24; 51% refers to plasma protein carbonyls after 6 weeks. Study doses and conditions differ from AGE DEFENSE.